Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sandler

Showing results (701-710 of 870) with videos related to

Pageof 87
Sort By:
Journal of Neuro-Oncology|November 8, 2005
Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patientsNicole E Marshall, Karla V Ballman, John C Michalak, et al.
Urologic Oncology|May 18, 2024
Variation in content discussed by specialty in consultations for clinically localized prostate cancerNadine A Friedrich, Michael Luu, Rebecca Gale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02Gerald E Hanks, Thomas F Pajak, Arthur Porter, et al.
Cancer|November 21, 2012
Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14David D Howell, Jennifer L James, William F Hartsell, et al.
Skeletal Radiology|November 22, 2011
Skeletal muscle metastases: a three-part study of a not-so-rare entityTamara Miner Haygood, Jason Wong, Jennifer Cha Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2013
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trialJeff M Michalski, Yan Yan, Deborah Watkins-Bruner, et al.
International Journal of Radiation Oncology, Biology, Physics|May 6, 2008
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10Li-Yan Khor, Kyounghwa Bae, Tahseen Al-Saleem, et al.
Nature Neuroscience|July 27, 2019
Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysisMichael X Henderson, Eli J Cornblath, Adam Darwich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Living with prostate cancer: patients' and spouses' psychosocial status and quality of lifeLaurel L Northouse, Darlene W Mood, James E Montie, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy)Janice K Ryu, Kathryn Winter, Jeff M Michalski, et al.
Pageof 87

Showing results (701-710 of 870) with videos related to

Sort By:
Pageof 87
Journal of Neuro-Oncology|November 8, 2005
Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patientsNicole E Marshall, Karla V Ballman, John C Michalak, et al.
Urologic Oncology|May 18, 2024
Variation in content discussed by specialty in consultations for clinically localized prostate cancerNadine A Friedrich, Michael Luu, Rebecca Gale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02Gerald E Hanks, Thomas F Pajak, Arthur Porter, et al.
Cancer|November 21, 2012
Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14David D Howell, Jennifer L James, William F Hartsell, et al.
Skeletal Radiology|November 22, 2011
Skeletal muscle metastases: a three-part study of a not-so-rare entityTamara Miner Haygood, Jason Wong, Jennifer Cha Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2013
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trialJeff M Michalski, Yan Yan, Deborah Watkins-Bruner, et al.
International Journal of Radiation Oncology, Biology, Physics|May 6, 2008
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10Li-Yan Khor, Kyounghwa Bae, Tahseen Al-Saleem, et al.
Nature Neuroscience|July 27, 2019
Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysisMichael X Henderson, Eli J Cornblath, Adam Darwich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Living with prostate cancer: patients' and spouses' psychosocial status and quality of lifeLaurel L Northouse, Darlene W Mood, James E Montie, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy)Janice K Ryu, Kathryn Winter, Jeff M Michalski, et al.
Pageof 87